Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway
Cited by 19
Related Papers
Single‐Cell Transcriptome Profiling Reveals Multicellular Ecosystem of Nucleus Pulposus during Degeneration Progression
|Advanced Science|2021|122
Isoginkgetin-loaded reactive oxygen species scavenging nanoparticles ameliorate intervertebral disc degeneration via enhancing autophagy in nucleus pulposus cells
|Journal of Nanobiotechnology|2023|36
Melatonin Protects Intervertebral Disc from Degeneration by Improving Cell Survival and Function via Activation of the ERK1/2 Signaling Pathway
|Oxidative Medicine and Cellular Longevity|2019|27
Theaflavin‐3,3 <sup>′</sup>‐Digallate Protects Cartilage from Degradation by Modulating Inflammation and Antioxidant Pathways
|Oxidative Medicine and Cellular Longevity|2022|20
FK506 Induces the TGF-β1/Smad 3 Pathway Independently of Calcineurin Inhibition to Prevent Intervertebral Disk Degeneration
|Frontiers in Cell and Developmental Biology|2020|6